Citation Impact
Citing Papers
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies
2005
Glyconanoparticles as multifunctional and multimodal carbohydrate systems
2013
Current perspectives of epothilones in breast cancer
2008
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Parkinson's disease
2021 Standout
Bowel Disorders
2016 Standout
Combining immunotherapy and targeted therapies in cancer treatment
2012
Natural products: An evolving role in future drug discovery
2011 Standout
Development of Novel Chemotherapeutic Agents to Evade the Mechanisms of Multidrug Resistance (MDR)
2005
Irritable bowel syndrome
2016 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Epothilones in the treatment of cancer
2006
Targeting apoptosis in cancer therapy
2020 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Investigation of Colonic and Whole-Gut Transit With Wireless Motility Capsule and Radiopaque Markers in Constipation
2009
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
2013
Update on tubulin-binding agents
2005
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Delivering Colloidal Nanoparticles to Mammalian Cells: A Nano–Bio Interface Perspective
2014
Combination therapy in combating cancer
2017 Standout
New-Generation Platinum Agents for Solid Tumors
2009
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
2018
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Works of Greg Wilding being referenced
Biological effects and clinical significance of lenalidomide‐induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response
2011
559 Pharmacokinetics of GW572016 in an ascending dose tolerability study of phase I cancer patients
2003
Phase I study using continuous intravenous (CI) KOS-862 (Epothilone D) in patients with solid tumors
2004
Relationship Between the Colonic Transit of Wireless Capsule (Smartpill®) and Radio Opaque Markers in Constipation
2008
Vowel Acoustics in Parkinson's Disease and Multiple Sclerosis: Comparison of Clear, Loud, and Slow Speaking Conditions
2013
Design and Synthesis of Multifunctional Gold Nanoparticles Bearing Tumor-Associated Glycopeptide Antigens as Potential Cancer Vaccines
2012
Population-based analysis of cancer control of partial nephrectomy for high-risk localized renal cell carcinoma.
2012
Phase I study of satraplatin and docetaxel in solid malignancies
2008